Weight Symptoms and Causes

Birth Weight is the first Weight of your baby, taken just after he or she is born. A low birth Weight is less than 5.5 pounds. A high birth Weight is more than 8.8 pounds.

A low birth Weight baby can be born too small, too early (premature), or both. This can happen for many different reasons. They include health problems in the mother, genetic factors, problems with the placenta and substance abuse by the mother.

Some low birth Weight babies may be more at risk for certain health problems. Some may become sick in the first days of life or develop infections. Others may suffer from longer-term problems such as delayed motor and social development or learning disabilities.

High birth Weight babies are often big because the parents are big, or the mother has diabetes during pregnancy. These babies may be at a higher risk of birth injuries and problems with blood sugar.

Weight Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.

To evaluate the impact of a 16-week, group-based Weight loss intervention upon body Weight in a group of cancer survivors.; To evaluate the impact of a 16-week Weight loss intervention upon the following in a group of cancer survivors.

Vascular activity: differences between lean and abdominally overWeight / obese men and effects of Weight loss; Vascular function markers related to the macrovasculature: differences between lean and abdominally overWeight / obese men and effects of Weight loss; Vascular function markers related to the microvasculature: differences between lean and abdominally overWeight / obese men and effects of Weight loss; Metabolic risk markers related to the metabolic syndrome: differences between lean and abdominally overWeight / obese men and effects of Weight loss

The number of women with a Weight gain during pregnancy within IOM´s recommendation is compared between study groups.; Weight retention(kg) up until one year after delivery is compared between study groups.; Number of fetal and maternal complications in pregnancy is compared between study groups; Number of fetal and maternal complications during delivery is compared between study groups; Child birth Weight and Weight development of the child up to one year of age is compared between study groups.

Weight change from initial assessment to the 3-month follow-up assessment measured on a digital scale to the nearest 0.1-kilogram; Weight change from the initial assessment to the 12 month assessment measured on a digital scale to the nearest 0.1-kilogram; Weight change from the 3 month assessment to the 12 month assessment measured on a digital scale to the nearest 0.1-kilogram

Weight change from the initial assessment to the 12-month assessment measured on a digital scale to the nearest 0.1-kilogram; Direction of social comparison between participants and their Peer or Mentor Weight loss coach

Mean Weight loss assessed with the digital scale; Changes in levels of total cholesterol; Changes in levels of markers of inflammation (C-reactive protein); Changes in levels of glucose; Number of drop-out participants; Average percentage of positive urinary ketone tests as a marker of dietary adherence; Number of Participant with reported side effects; Changes in quality-of-life as assessed by the Obesity and Weight Loss Quality-of-Life Questionnaire; Changes in levels of markers of inflammation (interleukin 6); Changes in levels of markers of inflammation (tumor necrosis factor - alpha); Changes in levels of markers of inflammation (leptin); Changes in levels of LDL-cholesterol; Changes in levels of HDL-cholesterol; Changes in levels of triglycerides

Proportion of pregnant women who gain more Weight during pregnancy than is recommended by the Institute of Medicine; Relationship between Weight gain during pregnancy, the mother's physical activity and diet on the chance of the mother getting diabetes during pregnancy; Relationship between Weight gain during pregnancy, the mother's physical activity and diet on the baby's Weight at birth; Relationship between Weight gain during pregnancy, the mother's physical activity and diet on the mother and baby's body fatness; Relationship between Weight gain during pregnancy, the mother's physical activity and diet on how much pregnancy Weight the mother keeps after she delivers her baby; Relationship between Weight gain during pregnancy, the mother's physical activity and diet on how much the baby eats

Ovulation during a Weight loss intervention in women with PCOS; Endometrial development during a Weight loss intervention in women with PCOS; Changes in metabolism and body composition during a Weight loss intervention in women with PCOS; Changes in ovarian morphology, metabolism, and body composition in the six months after a Weight loss intervention in women with PCOS

If you think you may have a medical emergency, call your doctor or 911 immediately.

By accessing this website, you are indicating your acknowledgement and acceptance of these Terms of Use. These Terms of Use are subject to change by WinFirst LLC at any time in its discretion. Your use of WinFirst LLC Site after such changes are implemented constitutes your acknowledgement and acceptance of the changes. Please consult these Terms of Use regularly.
PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.